Sign in
Taking people in United StatesNo phase

Tracking safety and real-world results of transcatheter aortic valve replacement for aortic valve stenosis

Collects health records of adults with aortic stenosis who have transcatheter valve replacement.

Key facts

Who runs it
The Society of Thoracic Surgeons
Where
Washington D.C., United StatesSee the site
Trial code
Registry title
STS/ACC Transcatheter Valve Therapy Registry (TVT Registry)
Status
Recruiting
People taking part
16,000 people, planned
Started
Jun 2012
Expected to end
Jun 2035
Type of study
Observational
Treatments tested
  • Transcatheter Aortic Valve Replacement
Record updated
25 August 2022

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who have a transcatheter aortic valve replacement (TAVR) for severe aortic stenosis. It is a registry that tracks safety and real-world results.

Age
18 years or older
Sex
All sexes can join.
Disease stage
Severe aortic stenosis (narrowing of the main heart valve).
Earlier treatment
People in the registry have the TAVR procedure, a valve replacement done through a tube in a blood vessel.

Main reasons for not taking part

  • People younger than 18 years cannot join.

The registry criteria, word for word

Show the criterionShow less

Who can take part

  • 18 years or older

Where in United States

  • American College of CardiologyWashington D.C., United StatesContact: Joan MichaelsTaking people

About the trial

What the trial wants to find out

The TVT Registry™ is a benchmarking tool developed to track patient safety and real-world outcomes related to the transcatheter aortic valve replacement (TAVR) procedure. Created by The Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC), the TVT Registry is designed to monitor the safety and efficacy of this new procedure for the treatment of aortic stenosis.

The group in the trial

  • TAVR Patients

    Will include all patients 18 years or over who undergo Transcatheter Aortic Valve Replacement (TAVR) for severe aortic stenosis. The sample size will include all patients entered into the Registry.

    Treatment: Transcatheter Aortic Valve Replacement

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Society of Thoracic Surgeons and American College of Cardiology Transcatheter Valve Therapy Registry (STS/ACC TVT Registry).
Plain-language title
Tracking safety and real-world results of transcatheter aortic valve replacement for aortic valve stenosisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Publications
Record updated
25 August 2022